Summit Trail Advisors’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,346
| Closed | -$5K | – | 426 |
|
|
2022
Q3 | $5K | Hold |
1,346
| – | – | ﹤0.01% | 376 |
|
|
2022
Q2 | $8K | Hold |
1,346
| – | – | ﹤0.01% | 384 |
|
|
2022
Q1 | $15K | Hold |
1,346
| – | – | ﹤0.01% | 326 |
|
|
2021
Q4 | $20K | Hold |
1,346
| – | – | ﹤0.01% | 296 |
|
|
2021
Q3 | $40K | Hold |
1,346
| – | – | ﹤0.01% | 262 |
|
|
2021
Q2 | $62K | Hold |
1,346
| – | – | 0.01% | 218 |
|
|
2021
Q1 | $81K | Hold |
1,346
| – | – | 0.01% | 188 |
|
|
2020
Q4 | $71K | Buy |
+1,346
| New | +$71K | 0.01% | 183 |
|
|
2020
Q3 | – | Sell |
-1,346
| Closed | -$117K | – | 241 |
|
|
2020
Q2 | $117K | Hold |
1,346
| – | – | 0.02% | 161 |
|
|
2020
Q1 | $78K | Hold |
1,346
| – | – | 0.02% | 120 |
|
|
2019
Q4 | $97K | Hold |
1,346
| – | – | 0.06% | 71 |
|
|
2019
Q3 | $82K | Buy |
+1,346
| New | +$82K | 0.03% | 88 |
|